Future of gene therapies for hemophilia B treatment holds great promise, offering the potential for a paradigm shift in treatment approaches.
Find MoreInsulin Pens Market is generating huge demand due to rising prevalence of diabetes. Companies are developing innovative Insulin Pens.
Find MoreFollowing two prior rejections, FDA has granted long-awaited approval to Ardelyx's Xphozah for chronic kidney disease treatment in adults.
Find MoreOn October 13 2023, the FDA has granted approval for Pfizer’s ulcerative colitis treatment, Etrasimod, under the brand name Velsipity.
Find MoreAllergies are on the rise globally, affecting millions of people and significantly impacting their quality of life. The ability to accurately diagnose and manage allergies is crucial for both patients and healthcare providers. With the rising prevalence of allergy, the demand for Allergy Diagnostics has increased m...
Find MoreRare eye diseases can pose burden on patients. Top rare eye diseases are Stargardt Disease, Retinitis Pigmentosa, LHON, Retinoblastoma, LSCD
Find MoreOn September 29, 2023, FDA approved EXXUA, the ER gepirone hydrochloride tablets by Fabre-Kramer, for major depressive disorder treatment.
Find MoreImmunomodulators are reshaping the healthcare market outlook with their diverse benefits and applications, thereby improving health outcomes.
Find MoreFDA approved Rivfloza for primary hyperoxaluria treatment. This announcement comes as Novo continues to make strides in field of RNAi drugs.
Find MoreSince scopolamine transdermal patch FDA approval, no other treatments approved in US for nausea and vomiting induced by motion sickness.
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.